Published in Basic Res Cardiol on November 23, 1983
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol (1961) 113.20
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem (1953) 16.50
Plasma membranes of mammalian cells: a review of methods for their characterization and isolation. J Cell Biol (1973) 2.99
Specific uncoupling of excitation and contraction in mammalian cardiac tissue by lanthanum. J Gen Physiol (1970) 1.45
Calcium movements in relation to heart function. Basic Res Cardiol (1982) 1.26
Thyroxine-induced redistribution of isoenzymes of rabbit ventricular myosin. Circ Res (1982) 1.24
Isolation and characterization of cardiac sarcolemma. Biochim Biophys Acta (1979) 1.15
The structure and function of the myocardial cell surface. Am J Physiol (1978) 1.03
Intact vesicles of canine cardiac sarcolemma: evidence from vectorial properties of Na+, K+-ATPase. Circ Res (1976) 0.92
Calcium accumulation and cyclic AMP-stimulated phosphorylation in plasma membrane-enriched preparations of myocardium. Arch Biochem Biophys (1976) 0.92
Isolation of plasma membrane from cardiac muscle. Biochem Biophys Res Commun (1971) 0.91
Two orientations of isolated cardiac sarcolemmal vesicles separated by affinity chromatography. Anal Biochem (1980) 0.86
Preparation and properties of highly enriched cardiac sarcolemma from isolated adult myocytes. J Biol Chem (1980) 0.83
Isolation of sealed vesicles highly enriched with sarcolemma markers from canine ventricle. Biochim Biophys Acta (1980) 0.83
Calcium binding and ATPase activities of heart sarcolemma. J Biochem (1976) 0.83
Properties of 5'-nucleotidase in rat heart sarcolemma. Biochim Biophys Acta (1983) 0.82
Ca2+- and Mg2+-dependent ATPase activities in the deoxycholate-treated rat heart sarcolemma. Int J Biochem (1982) 0.82
Effects of acebutolol, practolol and propranolol on the rat heart sarcolemma. Biochem Pharmacol (1977) 0.81
Negatively charged sites and calcium binding in the isolated rat heart sarcolemma. Basic Res Cardiol (1981) 0.81
Effects of lanthanum on the heart sarcolemmal ATPase and calcium binding activities. Can J Physiol Pharmacol (1979) 0.80
Ca2+/Mg2+ ATPase activities of heart sarcolemma, microsomes, and mitochondria. J Biochem (1977) 0.79
Calcium-binding sites in rat myocardial sarcolemma. Arch Biochem Biophys (1977) 0.78
Mass isolation of cell surface membrane fragments from pigeon heart. Biochim Biophys Acta (1979) 0.78
Structure-function relationship in heart sarcolemma. Adv Myocardiol (1980) 0.77
Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res (1993) 2.11
Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol (1982) 1.87
The role of oxidative stress in the genesis of heart disease. Cardiovasc Res (1998) 1.85
Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol (1996) 1.57
Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. Am J Physiol Heart Circ Physiol (2007) 1.52
Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation (1997) 1.50
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol (1996) 1.50
Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol (1983) 1.36
Free radicals and the heart. J Pharmacol Toxicol Methods (1993) 1.27
Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol (1994) 1.26
Calcium movements in relation to heart function. Basic Res Cardiol (1982) 1.26
Structural and functional changes associated with failure and recovery of hearts after perfusion with Ca2+-free medium. J Mol Cell Cardiol (1975) 1.22
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal (2001) 1.19
Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation (1994) 1.16
Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion. Studies on isolated canine ventricular tissues. Circ Res (1985) 1.16
Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol (1983) 1.15
Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med (1999) 1.14
Oxidative stress and heart failure. Mol Cell Biochem (1996) 1.12
Myocardial cation contents during induction of calcium paradox. Am J Physiol (1979) 1.11
Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol (1995) 1.11
Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol (2000) 1.09
Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation (1995) 1.07
Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol (1999) 1.07
Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol (1991) 1.07
Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol Rev (1999) 1.07
Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem (2003) 1.06
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes (2001) 1.04
Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol (1991) 1.03
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02
Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep (1998) 1.02
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02
Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation (2000) 1.02
Metallothioneins, oxidative stress and the cardiovascular system. Toxicology (2000) 1.01
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol (2005) 0.99
Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Am J Physiol (1989) 0.99
Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res (2000) 0.98
Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol (1985) 0.98
Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci U S A (1983) 0.98
Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J Pharmacol Exp Ther (1999) 0.98
Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol (1983) 0.98
Alterations in cardiac membrane Ca2+ transport during oxidative stress. Mol Cell Biochem (1990) 0.97
Correlation between changes in the endogenous energy stores and myocardial function due to hypoxia in the isolated perfused rat heart. Can J Physiol Pharmacol (1972) 0.97
Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency. Ann Thorac Surg (2001) 0.96
Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem (2000) 0.96
Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol (1997) 0.95
Positive and negative inotropic effects of phorbol 12-myristate 13-acetate: relationship to PKC-dependence and changes in [Ca2+]i. J Mol Cell Cardiol (1992) 0.95
Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol. J Mol Cell Cardiol (1975) 0.95
Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J (1992) 0.94
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J (1981) 0.94
Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol (1981) 0.94
Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol (1985) 0.94
Role of extracellular matrix proteins in heart function. Mol Cell Biochem (1993) 0.93
Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am J Physiol (1983) 0.93
Excitation-contraction coupling in heart. 3. Evidence against the involvement of adenosine cyclic 3',5'-monophosphate in calcium transport by sarcotubular vesicles of canine myocardium. Mol Pharmacol (1970) 0.93
Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem (1997) 0.93
Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol (1987) 0.93
Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion. Am J Cardiol (1975) 0.92
Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol (1993) 0.92
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J (2003) 0.92
Direct effects of adriamycin on the rat heart sarcolemma. Res Commun Chem Pathol Pharmacol (1984) 0.92
Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes (1988) 0.92
An ultrastructural study of the first cleavage of Xenopus embryos. J Ultrastruct Res (1974) 0.92
Myocardial cell damage during experimental infective endocarditis. Lab Invest (1975) 0.91
Excitation-contraction coupling in heart. VI. Demonstration of calcium activated ATPase in the dog heart sarcolemma. Life Sci I (1971) 0.91
Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim Biophys Acta (1996) 0.91
Regulatory role of membrane systems in heart function. Can J Physiol Pharmacol (1977) 0.91
Takayasu arteritis may be underdiagnosed in North America. Can J Cardiol (1995) 0.90
Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol (1992) 0.90
Oscillations of intramuscular pH in perfused rat heart. Can J Physiol Pharmacol (1973) 0.90
Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy. Can J Cardiol (1999) 0.90
Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res (1989) 0.90
Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol (1989) 0.90
Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. J Cardiovasc Pharmacol (1994) 0.89
Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res (2000) 0.89
Subcellular calcium transport in failing hearts due to calcium deficiency and overload. Am J Physiol (1976) 0.89
Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther (1998) 0.89
Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochim Biophys Acta (1991) 0.89
Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol (1992) 0.89
Characterization of insulin receptors in cardiac sarcolemmal and sarcoplasmic reticular membranes. J Cardiovasc Pharmacol (1987) 0.88
Abnormalities in heart membranes and myofibrils during bacterial infective cardiomyopathy in the rabbit. Circ Res (1976) 0.88
Involvement of membrane systems in heart failure due to intracellular calcium overload and deficiency. J Mol Cell Cardiol (1976) 0.88
Mechanism for depression of heart sarcolemmal Ca2+ pump by oxygen free radicals. Am J Physiol (1989) 0.88
Anti-atherosclerotic molecules targeting oxidative stress and inflammation. Curr Pharm Des (2009) 0.88
Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys (2001) 0.88
Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol (1979) 0.88
Role of H2O2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem (1998) 0.87
Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am J Physiol (1991) 0.87
Formation of gigantic mitochondria in hypoxic isolated perfused rat hearts. Experientia (1969) 0.87
Mobilization of antioxidant vitamin pools and hemodynamic function after myocardial infarction. Circulation (1999) 0.86
Myocardial oxidative stress changes during compensated right heart failure in rats. Mol Cell Biochem (1999) 0.86
Influence of reducing agents on adrenochrome-induced changes in the heart. Arch Pathol Lab Med (1981) 0.86
Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J Mol Cell Cardiol (1999) 0.86